| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.046 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |